The Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) launched by Zhuhai Livzon Diagnostics Inc. with approval is only designated for in vitro qualitative detection of IgM / IgG antibody to coronavirus (2019-nCoV) in human serum, plasma and venous whole blood, and is only used as supplementary detection index for suspected case with negative result of 2019-nCoV nucleic acid detection, or used in conjunction with nucleic acid detection for diagnosis of suspected case. Medical institutions use only. It only takes 15 minutes to interpret the result.
The Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) developed by our company have received the registration certificate from the National Medical Products Administration recently. In order to prevent some organizations and individuals from carrying out false publicity and sales by falsely using the name of “Zhuhai Livzon Diagnostics Inc.”, we hereby declare that:
Nanfang Daily (Reporter / Xu Lin Correspondent / Yue Zong) On February 12, Mr. Li Xi, the Secretary of the Guangdong Provincial Committee of the CPC, went to Zhuhai to carry out investigation and inspection on comprehensive study and implementation of the spirit of important indications of General Secretory Xi Jinping for COVID-19 prevention and control, implementation of the spirit of the meetings of the Central Leading Group for COVID-19 Prevention and Control, and further implementation of measures for epidemic prevention & control and work resumption.
It is said that, The "Lavender Reagent 2019 New Product Seminar" held recently was very lively. I heard that there was a lot of people on the scene at the Livzon reagent theme exhibition hall. I heard that many new products of Livzon Reagent have been strongly watched!